JSC MEDICAL - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 173,725 | 282,600 | 155,920 | 272,280 | 256,880 | 317,950 | 411,230 | 469,230 |
| Profit before tax | 112,124 | 173,808 | 94,054 | 177,475 | 137,704 | 158,452 | 184,468 | 193,326 |
| Net profit | 106,505 | 165,115 | 89,285 | 168,597 | 130,770 | 134,696 | 156,344 | 166,045 |
| Equity | 136,847 | 201,962 | 138,306 | 212,785 | 225,908 | 313,546 | 469,890 | 635,935 |
| Liabilities | 11,923 | 19,004 | 12,765 | 14,202 | 16,170 | 29,990 | 42,418 | 54,738 |
| Non-current assets | 2,944 | 137 | 2 | 2 | 2 | 258,662 | 416,930 | 634,090 |
| Current assets | 145,826 | 220,829 | 151,069 | 226,985 | 242,076 | 84,874 | 95,378 | 56,583 |
| Total assets | 148,770 | 220,966 | 151,071 | 226,987 | 242,078 | 343,536 | 512,308 | 690,673 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 64,480 | 89,882 | 96,603 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.0% | +62.7% | -44.8% | +74.6% | -5.7% | +23.8% | +29.3% | +14.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 71.6% | 74.7% | 59.1% | 74.3% | 54.0% | 39.2% | 30.5% | 24.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 77.8% | 81.8% | 64.6% | 79.2% | 57.9% | 43.0% | 33.3% | 26.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 61.3% | 58.4% | 57.3% | 61.9% | 50.9% | 42.4% | 38.0% | 35.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 64.5% | 61.5% | 60.3% | 65.2% | 53.6% | 49.8% | 44.9% | 41.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 86,863 | 94,200 | 51,973 | 90,760 | 85,627 | 141,311 | 176,244 | 156,410 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
JSC MEDICAL - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-22 | 749.60 |
| 2026-07-16 | 2026-07-17 | 749.60 |
| 2026-06-16 | 2026-06-17 | 744.33 |
| 2026-05-17 | 2026-05-18 | 749.55 |
| 2026-03-17 | 2026-03-27 | 601.52 |
| 2026-02-18 | 2026-02-22 | 508.62 |
| 2024-07-16 | 2024-07-22 | 92.86 |
| 2023-02-06 | 2023-02-12 | 0.21 |
| 2023-01-23 | 2023-02-03 | 0.21 |
| 2022-12-16 | 2023-01-09 | 0.01 |
| 2022-11-17 | 2022-11-18 | 238.02 |
| 2022-02-17 | 2022-03-07 | 0.42 |
| 2021-10-18 | 2021-10-20 | 232.26 |
JSC MEDICAL - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company JSC MEDICAL is: 7,429 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 7429.04 |
| 2026-08-28 | 2026-08-31 | 7417.02 |
| 2026-07-05 | 2026-07-07 | 9014.9 |
| 2026-06-30 | 2026-07-04 | 12647.67 |
| 2026-06-28 | 2026-06-29 | 12647.75 |
| 2026-06-03 | 2026-06-04 | 4.5 |
| 2026-06-01 | 2026-06-02 | 2765.49 |
| 2026-05-28 | 2026-05-31 | 2760.99 |
| 2026-05-15 | 2026-05-19 | 15.99 |
| 2026-05-08 | 2026-05-14 | 4.26 |
| 2026-05-06 | 2026-05-07 | 5437.31 |
| 2026-05-01 | 2026-05-05 | 5460.11 |
| 2026-04-30 | 2026-04-30 | 5455.85 |
| 2026-04-10 | 2026-04-29 | 8.85 |
| 2026-04-05 | 2026-04-09 | 7.5 |
| 2026-04-01 | 2026-04-04 | 1730.78 |
| 2026-03-29 | 2026-03-31 | 1803.94 |
| 2026-03-22 | 2026-03-28 | 5989.98 |
| 2026-03-12 | 2026-03-12 | 13.98 |
| 2026-03-08 | 2026-03-11 | 11.06 |
| 2026-03-02 | 2026-03-07 | 6141.36 |
| 2026-02-16 | 2026-02-21 | 10.01 |
| 2026-02-03 | 2026-02-15 | 7.28 |
| 2026-01-31 | 2026-02-02 | 4397.35 |
| 2026-01-29 | 2026-01-30 | 4680.1 |
| 2026-01-08 | 2026-01-28 | 9.1 |
| 2026-01-01 | 2026-01-07 | 5017.19 |
| 2025-12-29 | 2025-12-31 | 15.59 |
| 2025-12-20 | 2025-12-23 | 7500.85 |
| 2025-12-18 | 2025-12-19 | 7500.86 |
| 2025-12-11 | 2025-12-17 | 0.86 |
| 2025-12-09 | 2025-12-10 | 14.52 |
| 2025-12-08 | 2025-12-08 | 3288.17 |
| 2025-12-05 | 2025-12-07 | 3281.99 |
| 2025-12-02 | 2025-12-04 | 5342.91 |
| 2025-11-28 | 2025-12-01 | 5334.57 |
| 2025-10-02 | 2025-10-05 | 1610.86 |
| 2025-09-28 | 2025-10-01 | 1608.76 |
| 2025-09-22 | 2025-09-23 | 7.76 |
| 2025-09-19 | 2025-09-19 | 7463.99 |
| 2025-08-07 | 2025-08-12 | 13.99 |
| 2025-08-02 | 2025-08-06 | 12.06 |
| 2025-07-28 | 2025-08-01 | 7430.0 |
| 2025-07-09 | 2025-07-20 | 131.64 |
| 2025-07-08 | 2025-07-08 | 124.58 |
| 2025-07-07 | 2025-07-07 | 26272.05 |
| 2025-07-02 | 2025-07-06 | 26229.61 |
| 2025-07-01 | 2025-07-01 | 26524.97 |
| 2025-06-30 | 2025-06-30 | 26517.83 |
| 2025-06-28 | 2025-06-29 | 26442.83 |
| 2025-06-19 | 2025-06-27 | 19111.83 |
| 2025-04-08 | 2025-04-10 | 19.01 |
| 2025-04-03 | 2025-04-07 | 15.69 |
| 2025-04-02 | 2025-04-02 | 6161.69 |
| 2025-03-28 | 2025-04-01 | 6146.93 |
| 2025-03-23 | 2025-03-27 | 0.93 |
| 2025-03-22 | 2025-03-22 | 1.6 |
| 2025-03-20 | 2025-03-21 | 5944.93 |
| 2025-03-02 | 2025-03-19 | 4.33 |
| 2025-02-02 | 2025-02-10 | 0.75 |
| 2025-01-31 | 2025-01-31 | 2620.91 |
| 2025-01-30 | 2025-01-30 | 2621.43 |
| 2024-12-30 | 2024-12-30 | 1650.08 |
| 2024-12-06 | 2024-12-16 | 7.2 |
| 2024-12-03 | 2024-12-05 | 5.38 |
| 2024-11-28 | 2024-12-02 | 6748.28 |
| 2024-11-17 | 2024-11-18 | 16.28 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
JSC MEDICAL, UAB (code 302732571) is a Private Limited Liability Company engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €469.2K and net profit of €166.0K, with a profit margin of 35.4%. Revenue increased by 14.1% year on year and by 47.6% over two years, showing a steady expansion from €317.9K in 2023 to €411.2K in 2024 and further in 2025. Net profit also rose over the period, from €134.7K in 2023 to €156.3K in 2024 and €166.0K in 2025. The balance sheet strengthened materially: total assets reached €690.7K in 2025, compared with €343.5K in 2023, while equity increased to €635.9K and liabilities remained modest at €54.7K. The equity ratio stood at 92.1%, debt-to-equity at 0.09, and asset turnover at 0.68x. Revenue per employee was €156.4K and profit per employee €55.3K, indicating solid productivity.